Suchergebnisse - "Jørgen Vestbo"

PubPharm (61)

41

COPD monocytes demonstrate impaired migratory ability

in: Respiratory Research | 2017

von Arjun K Ravi | Jonathan Plumb | Rosemary Gaskell | +6

42

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

enthalten in: American journal of respiratory and critical care medicine | 2017

von Claus F Vogelmeier | Gerard J Criner | Fernando J Martinez | +19

43

Effect of Fluticasone Furoate and Vilanterol on Exacerbations of Chronic Obstructive Pulmonary Disease in Patients with Moderate Airflow Obstruction

enthalten in: American journal of respiratory and critical care medicine | 2017

von Fernando J Martinez | Jørgen Vestbo | Julie A Anderson | +10

44

PROGNOSTIC IMPORTANCE OF BLOOD PRESSURE AND HEART RATE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: THE SUMMIT TRIAL

enthalten in: Journal of the American College of Cardiology | 2017

von James Brian Byrd | David E Newby | Julie A Anderson | +8

45

Fletcher and Peto 40 Years On A Tribute and Reflection

enthalten in: American journal of respiratory and critical care medicine | 2017

von Jørgen Vestbo | Peter Lange

46

Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk

enthalten in: Heart | 2017

von Robert D Brook | Julie A Anderson | Peter MA Calverley | +9

47

Triple Therapy in Chronic Obstructive Pulmonary Disease/Reply

enthalten in: American journal of respiratory and critical care medicine | 2017

von Dave Singh | Jørgen Vestbo | David A Lipson | +10

48

Exposure Interaction: A Lifelong Phenomenon with Relevance to Chronic Obstructive Pulmonary Disease

enthalten in: American journal of respiratory and critical care medicine | 2017

von Jørgen Vestbo | Peter Lange

49

Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomised controlled trial

enthalten in: The lancet | 2017

von Ashley Woodcock | Jørgen Vestbo | Nawar Diar Bakerly | +82

50

Pneumonia risk with inhaled fluticasone furoate and vilanterol in COPD patients with moderate airflow limitation: The SUMMIT trial

enthalten in: Respiratory medicine | 2017

von Courtney Crim | Peter MA Calverley | Julie A Anderson | +8